Research theme for competitive and other funds (8)：
2021 - 2026 トリプレットリピート病のリピート長変動機構解明とリピート短縮治療の基盤確立
2019 - 2022 トリプレットリピート病のリピート短縮による根源的治療法の開発
2016 - 2020 筋強直性ジストロフィーの包括的治療法確立
2014 - 2018 Chemical Biology Studies on Trinucleotide Repeat Disease using Repeat-Binding Molecules
2014 - 2017 Myotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instability
2015 - 2017 Allele specific inhibition of mutant mRNA expression for repeat expansion disorders
2013 - 2015 Modulation of repeat size in trinucleotide repeat expansion disorders
2012 - 2013 トリプレットリピート病におけるリピート伸長機構の解明と制御
Show all
Papers (106)：
FUMITAKA SHIMIZU, Nakamori M. Blood-Brain Barrier Disruption in Neuroimmunological Disease. International journal of molecular sciences. 2024
Hicks SM, Frias JA, Mishra SK, Scotti M, Muscato DR, Valero MC, Adams LM, Cleary JD, Nakamori M, Wang E, et al. Alternative splicing dysregulation across tissue and therapeutic approaches in a mouse model of myotonic dystrophy type 1. Molecular therapy. Nucleic acids. 2024
Kenya Kubo, Yoshinori Oie, Ryota Koto, Nozomi Nishida, Chifune Kai, Sayo Maeno, Tomoya Kubota, Masayuki Nakamori, Masanori P Takahashi, Motokazu Tsujikawa, et al. Analysis of Corneal Phenotypes in Japanese Patients With Myotonic Dystrophy Type 1. Cornea. 2024
Naoki Suzuki, Madoka Mori-Yoshimura, Masahisa Katsuno, Masanori P Takahashi, Satoshi Yamashita, Yasushi Oya, Atsushi Hashizume, Shinichiro Yamada, Masayuki Nakamori, Rumiko Izumi, et al. Safety and efficacy of aceneuramic acid in GNE myopathy: open-label extension study. Journal of neurology, neurosurgery, and psychiatry. 2024
Sayo Maeno, Oie Y, Koto R, Nishida N, Yamashita A, Yoshioka M, Kai C, Soma T, Koh S, Masahito Yoshihara, et al. Comparison of Scheimpflug and Anterior Segment Optical Coherence Tomography Imaging Parameters for Japanese Patients With Fuchs Endothelial Corneal Dystrophy With and Without TCF4 Repeat Expansions. Cornea. 2024
T. Uehara, C. J. Choong, H. Hayakawa, Y. Kasahara, T. Nagata, T. Yokota, K. Baba, M. Nakamori, S. Obika, H. Mochizuki. Antisense Oligonucleotides Containing Amido-Bridged Nucleic Acid Downregulate SNCA Expression and Improve Motor Function in Parkinson's disease Mouse Models. MOVEMENT DISORDERS. 2017. 32
1993 - 1999 Osaka University Faculty of Medicine Medical School
Professional career (1)：
博士(医学) (大阪大学)
Work history (3)：
2023/01 - 現在 山口大学大学院医学系研究科 臨床神経学
2012/02 - 現在 Osaka University
2007/07 - 2012/01 University of Rochester Medical Center Neurology
Association Membership(s) (7)：
日本神経治療学会
, THE JAPAN SOCIETY OF HUMAN GENETICS
, THE JAPANESE SOCIETY OF INTERNAL MEDICINE
, JAPANESE SOCIETY OF NEUROLOGY
, 日本パーキンソン病・運動障害疾患学会
, 日本遺伝子細胞治療学会
, 日本筋学会
